Podcasts about Approval

A regulated exchange suing its own regulator almost never happens. The hosts trace why CME did it, and why the CFTC may have better odds than crypto Twitter thinks. Thanks to our sponsor!

We start with more crazy shark attack stories and Bobby has an idea for one of the survivors to make a lot of money from a bad situation. We also get an update on Raymundo and Scuba’s trip to Vegas. Bobby has a list of anti-alpha male qualities. He shares them to see who fits them the best Lunchbox or Eddie. They both get furious at each other. Josh Ross sits down with Bobby to talk about wrapping up his tour with Nate Smith, the hustle it took to get noticed. Josh opens up about investing everything back into his career, why success still never feels like enough, and why making his dad proud drives him! See omnystudio.com/listener for privacy information.

It's not really necessary that everybody approve of you and me and it really isn't necessary that we avoid being criticized. Broadcast #7505To help support this podcast, please visit walkwiththeking.org/donate and select "Podcast" from the dropdown menuA transcript of this broadcast is available on our website here. To hear more from Bob Cook, you can find Walk With The King on Facebook or Instagram.

June 23, 2026; 6pm: President Trump is threatening to sue ABC News again over its coverage of his multi-million dollar renovation of the Reflecting Pool. MS NOW's Ari Melber reports and is joined by esteemed veteran journalist Marty Baron, former executive editor for The Washington Post. Plus, comedian and actor Danny McBride joins "The Beat." To listen to this show and other MS podcasts without ads, sign up for MS NOW Premium on Apple Podcasts. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

TODAY ON THE ROBERT SCOTT BELL SHOW: Moderna mRNA Flu Jab Approval, EU GMO Deregulation, Taxpayer Drug Advertising, Copper Alzheimer's Research, Courage In Uncertainty, G. Edward Griffin, Red Pill Expo, Sitting Risk Study, and MORE! https://robertscottbell.com/moderna-mrna-fda-approval-gmo-deregulation-fallout-taxpayer-drug-advertising-copper-alzheimers-research-courage-in-uncertainty-g-edward-griffin-sitting-risk-study-and-more/ Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss pressing issues impacting the veterinary profession. New World Screwworm is back in the headlines, and it may be closer to home than you realize. In this episode, we sit down with special guest Dr. Jim Budde, Chief Pharmacy Officer at Instinct, to break down what clinicians need to know about this flesh-eating parasite, which drugs are being used to protect pets, and how to counsel clients who are asking questions. Brought to you by Zoetis Resources: https://www.wormsandgermsblog.com/ https://www.cliniciansbrief.com/article/new-world-screwworm-veterinary-guide https://www.avma.org/resources-tools/one-health/veterinarians-and-public-health/new-world-screwworm https://www.aphis.usda.gov/animals/animal-health/livestock-and-poultry-disease/stop-screwworm https://www.fda.gov/animal-veterinary/safety-health/new-world-screwworm-information-veterinarians#Approval https://www.aphis.usda.gov/animals/animal-health/livestock-and-poultry-disease/current-status/us-confirmed-cases-new-world https://www.apoquel.com Contact: podcast@instinct.vet Where To Find Us: Website: CliniciansBrief.com/Podcasts YouTube: Youtube.com/@clinicians_brief Facebook: Facebook.com/CliniciansBrief LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ Instagram: @Clinicians.Brief X: @CliniciansBrief The Team: Alyssa Watson, DVM - Host Beth Molleson, DVM - Host Alexis Ussery - Producer & Multimedia Specialist Disclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

Professor Donal O'Shea, specialist in obesity, responds to the National Centre for Pharmacoeconomics comments that Mounjaro could be deemed cost effective.

People pleasing is not kindness. It is fear dressed up as generosity. In this episode of the Via Stoica Podcast, we look honestly at what it means to stop living for other people's approval and start showing up as yourself.Welcome to the Via Stoica Podcast, the podcast on Stoicism. This episode builds directly on the previous conversation about the scripts we inherit. People pleasing is what happens when we keep performing that script out of fear rather than choice.Most of us learned early that being agreeable was rewarded and that causing discomfort came at a price. That lesson becomes a habit, the habit becomes a pattern, and the pattern quietly erodes the person underneath it. You say yes when you mean no. You manage the emotions of others at the expense of your own. You lose track of where their needs end and yours begin. Epictetus was clear: what others think of you is entirely outside your control. Handing your life over to opinions you cannot control is not kindness. It is fear with a generous face.This episode of the Via Stoica Podcast asks the question most people pleasers never stop to consider: am I doing this because it is right, or because I am afraid of what happens if I do not? The in-between is yours.Support the showviastoica.comYouTube: @viastoicaProduced by: Badmic.com

People matter. Our lives are shaped by the relationships around us. But for many of us, the quiet work of seeking approval is also the root of our exhaustion. We tie our worth to what others think, replay conversations, and never quite feel like we're truly enough.In this Season 4 finale of The Spacemakers, Daniel Sih and Matt Bain explore how to love people deeply without letting their opinions define us. They discuss and critique Mel Robbins' Let Them theory, summarise the AWARE framework, and offer a glimpse of what's coming in Season 5. It's a rich and fitting conclusion to our deepest season yet — and even if we've been talking about ‘enough', we secretly hope you'll want a little more.You can also explore previous seasons of The Spacemakers wherever you listen.Discover more:SPACEMAKERS WEBSITEYOUTUBESEASON 4 GUIDEThis season is made possible with support from our sponsors: Bulk Nutrients, Fullers Bookshop, and The Spacemakers Dojo.This podcast is recorded and produced by Wildersound and Production Farm StudiosMentioned in this episode:SM_ADVERT FINAL_DOJO 5_BUNNINGSSpacemakers - Dojo

By faith, we find our way to acceptance with and forgiveness from God.

Recorded as a special collaboration between Teacher Reporting Labs and On Our Minds, this episode brings educators and student hosts together for an unexpected conversation sparked by a community thread about VW buses. What begins with nostalgic memories of iconic road trips quickly expands into a reflection on freedom, identity, risk, and connection— through stories ranging from childhood van rides in Puerto Rico to cross-country adventures and near-miss highway moments. As teachers and teens swap travel memories, the conversation becomes less about vehicles and more about the journeys that shape how we see the world, the people we become on the road, and the meaning we carry with us long after the trip ends.Featured educators:Gil Garcia taught video production and broadcast journalism for 10 years at various schools in Austin, Texas.Trina Moore is a recently retired teacher who currently resides in Minneapolis, MN and never says no to a good road trip.Robert Casas teaches Digital Media Production, Broadcast Journalism, and AP Computer Science Principles at Westview High School in San Diego, where he has taught media courses since 2012.Road Trip Playlist: This conversation inspired us to create a community-powered road trip soundtrack featuring song picks from SRL educators and student journalists. Queue it up for your next adventure! SRL Summer Road Trip MixThis episode was produced by Senior Community Engagement Manager Emily Hope Dobkin with editing and mixing by Justin Rhodes. Zach and Helena from On Our Minds hosted this episode featuring SRL educators Trina Moore, Robert Casas and Gil Garcia. Additional production support was provided by Becky Wandel, Wyatt Mayes, Rawan Elbaba and Caroline Frentz. Graphics by Anurag Papolu. Approval and oversight by Marie Cusick and Executive Director Leah Clapman. Special thanks to WETA. 

A new poll on what Americans think of President Donald Trump's handling of Iran. AP correspondent Donna Warder reports.

Welcome to RealAg Radio for this Friday's edition of the Show! Today on the show, Shaun Haney is joined by Meagan Murdoch of Burson Group, Lyndsey Smith and Kelvin Heppner of RealAg for the RealAg Issues Panel! 00:00 - Coming up... 02:17 - Issues Panel with Shaun, Meagan, Lyndsey and Kelvin 16:12 - Issues Panel... Read More

Welcome to RealAg Radio for this Friday's edition of the Show! Today on the show, Shaun Haney is joined by Meagan Murdoch of Burson Group, Lyndsey Smith and Kelvin Heppner of RealAg for the RealAg Issues Panel! 00:00 - Coming up... 02:17 - Issues Panel with Shaun, Meagan, Lyndsey and Kelvin 16:12 - Issues Panel... Read More

President Trump and Iran's president have signed an initial agreement to end the war and reopen the Strait of Hormuz, but Israel was left out of the negotiations and Trump is openly criticizing its continued attacks in Lebanon.President Trump is once again putting Senate Republicans in a tough spot, he's holding back his pick for Director of National Intelligence until his demands are met, leaving his temporary pick Bill Pulte to lead the nation's intelligence agencies, with Trump threatening to block a key spy tool until he gets his way.And a new NPR/PBS News/ Marist poll finds Americans still aren't happy with the economy or with President Trump, his approval numbers at the lowest they've been, even dropping among groups that helped put him in office.Want more analysis of the most important news of the day, plus a little fun? Subscribe to the Up First newsletter.Today's episode of Up First was edited by Tina Kraja, Jason Breslow, Megan Pratz, Mohamad ElBardicy, and HJ Mai.It was produced by Ziad Buchh and Ava Pukatch.Our director is Christopher Thomas.We get engineering support from Neisha Heinis. Our technical director is Carleigh Strange.And our deputy Executive Producer is Kelley Dickens.(0:00) Introduction(01:57) Trump Signs Initial Deal With Iran(05:42) Trump Withholds DNI Nominee(09:31) Trump Approval PollSee pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy

Everyone wants approval from others. Imagine if you could get approval from GOD! You can. You need to!Join me for today's Daily Word & Prayer to learn more.Scripture Used in Today's MessageHebrews 11:2, 39Habakkuk 2:4John 12:42-43Galatians 1:10To find Tom on Instagram, Facebook, TiKTok, and elsewhere, go to linktr.ee/realtomshort

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a rapidly evolving landscape marked by significant scientific breakthroughs, regulatory shifts, and strategic business maneuvers. The pharmaceutical and biotech sectors are buzzing with renewed vigor, as evidenced by an impressive resurgence in mergers and acquisitions. A recent analysis by PwC reports that M&A activity has reached over $65 billion in deal value during the first quarter of 2026, marking the strongest quarter since 2020. This uptick underscores a robust confidence within the industry, with companies strategically leveraging these mergers to bolster their pipelines and explore new therapeutic territories. Eli Lilly's acquisition of non-opioid pain drugmaker 4E is a case in point, as it reflects a broader industry shift towards precision medicine and non-opioid pain management solutions—a response to growing concerns over opioid addiction. On the regulatory front, notable developments include Colorado's drug import plan receiving FDA approval. This marks a bold step in curbing drug costs across the U.S., although implementation challenges remain due to complex logistical and regulatory landscapes. Meanwhile, Novo Nordisk is expanding its global manufacturing footprint with a new plant in the Czech Republic for diabetes and obesity drugs, alongside a $29 million investment to upgrade its Chinese facility. This expansion aligns with Novo's strategic preparation to seek Chinese regulatory approval for its Wegovy pill, potentially transforming the obesity treatment landscape. In a move that could reshape vaccine development, Moderna is advancing its mRNA-based influenza vaccine candidate through regulatory channels. The FDA's favorable reviews ahead of an advisory committee meeting highlight the growing acceptance of mRNA technology beyond COVID-19 vaccines. This technology holds promise for transforming vaccine development across various infectious diseases. Precision oncology continues to grapple with translating scientific discoveries into practical applications that genuinely improve patient outcomes. The ASCO 2026 conference emphasized this critical transition from discovery to implementation as essential for advancing precision medicine. Turning to gene therapy, UniQure is preparing for a significant milestone—submitting an accelerated Biologics License Application for its Huntington's disease therapy. This follows a reversal by the FDA, which now considers UniQure's Phase 1/2 trial data sufficient for submission. Should this therapy gain approval, it would be groundbreaking as the first genetic medicine for Huntington's disease, setting a precedent for future gene therapies targeting other genetic disorders. In another strategic partnership, Jazz Pharmaceuticals has teamed up with AbCellera to develop T-cell-engaging antibodies for oncology indications, illustrating the potential financial rewards associated with innovative cancer therapies. This collaboration could yield up to $820 million per program and highlights how partnerships are crucial in expediting drug development timelines. These stories reflect broader industry trends emphasizing innovation and strategic partnerships while navigating complex regulatory landscapes. The focus on precision medicine and advanced biologics continues to drive scientific advancements, with companies like Vedana Therapeutics targeting unmet needs in neurology through novel therapeutic approaches. Meanwhile, international collaboration is gaining traction in regulatory processes. The newly launched transatlantic liaison program between the FDA and MHRA aims to accelerate drug approvals and foster innovation across borders—an initiative that underscores the importance of collaborative frameworks. However, not all news is optimistic. Be Biopharma's decision to terminate its hemophilia B cell therapy trial highlights the challenges companies face in competitive therapeutic areas. Despite previous optimism, similar withdrawals by Pfizer and BioMarin indicate the necessity for robust clinical data and clear market differentiation strategies. Furthermore, Merck's recent agreement with Protillion Technologies marks an increased focus on integrating artificial intelligence into drug discovery processes—a trend promising accelerated timelines and improved trial success rates. As these developments unfold, it's evident that the pharmaceutical and biotech sectors are at an intersection where scientific innovation meets strategic business decisions. The potential approval of UniQure's gene therapy could catalyze further advancements in genetic medicine—while M&A activities suggest an industry poised for transformative growth. For stakeholders—from researchers to executives—the ability to adapt to these dynamic changes will be crucial in shaping the future of drug development and patient care. In conclusion, these stories collectively paint a picture of an industry evolving through scientific breakthroughs while adapting through strategic business decisions. As new technologies integrate into this space alongside regulatory advancements in gene therapy, this period of transformation holds promising implications for addressing unmet medical needs and enhancing therapeutic outcomes globally.Support the show

The Rebbe responds to a request for approval to move elsewhere, reiterating his known opinion against leaving Paris, especially when connected to the yeshiva. He encourages utilizing one's strengths for their true mission, assuring that this will bring both spiritual and material success. https://www.torahrecordings.com/rebbe/igroskodesh/008/002/2265

Ryan and Kipp open with a conversation about building, creating, and the satisfaction that comes from seeing your work in the world before diving into another Ask Me Anything. This week, they tackle questions on approval seeking, self-development investments, measuring progress, unpopular opinions, intuition, instant gratification, rebuilding after divorce, and designing an intentional reset year. They also discuss why progress often feels invisible, how to involve family in personal goals, and why growth requires structure instead of endless information gathering. If you're trying to become more intentional and build a life with purpose, this episode delivers a practical perspective. SHOW HIGHLIGHTS 00:00 - Intro & catching up 06:48 - Approval seeking vs being likable 20:10 - Investing in self-development 24:30 - Measuring personal growth 26:42 - Unpopular opinions 35:49 - Escaping instant gratification 39:30 - Taking an adult gap year 45:53 - Showing progress to others 53:00 - Getting spouse buy-in for big goals 01:07:00 - Why systems beat information 01:09:30 - Wrap up   Battle Planners: Pick yours up today! Order Ryan's new book, The Masculinity Manifesto. For more information on the Iron Council brotherhood. Want maximum health, wealth, relationships, and abundance in your life? Sign up for our free course, 30 Days to Battle Ready  

Sen. Rick Scott, Republican Senator from Florida and former Governor of Florida, joined us on the Guy Benson Show today to discuss the latest on the Iran deal, as many from both sides of the political aisle raise questions surrounding details in the MOA. Sen. Scott also discussed the possibility of a third reconciliation bill, as well as the future of the Save America Act, and you can listen to the full interview below! Learn more about your ad choices. Visit podcastchoices.com/adchoices

Have you ever found yourself asking everyone else what they think before making a decision? Seeking reassurance or Looking for approval. Or maybe you try to make sure everyone is comfortable before allowing yourself to move forward. If so, this episode is for you. Many empaths spend years learning how to read a room, anticipate reactions, and make decisions based on how others might feel. But eventually, growth asks something different of us. It asks us to make our own experience matter too. In this episode, Brenda explores: ✨ Why self-trust is often a regulation issue rather than a confidence issue ✨ How empaths unintentionally make decisions by committee ✨ The hidden cost of organizing your life around other people's approval ✨ Why growth can feel threatening to belonging ✨ The identity shift that happens when you stop living for everyone else's comfort ✨ How "the pause" helps rebuild self-trust You'll also hear stories from POWER participants who have learned how to stop carrying what isn't theirs and trust themselves more deeply. Mentioned in this episode

ThePrintPod: New drugs reach India 5-6 years late, approval time must be cut down to 12-18 months—Pfizer India head

Your credit score went up but you still got denied for a loan, and the reason is debt-to-income ratio (DTI), the number lenders actually use to approve a mortgage and the one most credit repair clients never see coming. Join Our FREE Start Repairing Credit Challenge: HERE   The score gets your client noticed. The DTI gets them approved. So before you build a plan, ask every new client what they want to qualify for, what their timeline is, and what the rest of their financial picture looks like. Lead with the goal and you'll spot a denial before the lender does. DTI is simple math that almost nobody explains to clients. Add up their monthly debt payments, divide by their gross monthly income, and that percentage is the number. Most lenders want to see 43% or below, though conventional loans can stretch to 45% or even 50% with strong compensating factors like great credit and cash reserves. You move that number two ways, lowering the payments or raising documented income. Knocking out an installment loan with fewer than 10 payments left often gets the whole payment dropped from the calculation. Keep an eye on student loans, which can count against a client even in deferment. And when a big purchase is close, bring in a mortgage broker to run the exact numbers. Tune in!  P.S. Join the #1 event to grow your credit repair business: http://creditrepairexpo.com/   Key Takeaways: 00:00 Intro 01:30 Why a Higher Score Still Gets You Denied 03:34 The Three Questions to Ask Every New Client 04:46 Credit Score vs. DTI. Two Different Numbers 05:56 How to Calculate Your Client's DTI 07:40 The Ground Rule. No New Debt Until You Close 08:40 Why Student Loans Hurt Even in Deferment 09:32 Two Levers That Move the DTI 10:52 Final Thoughts Additional Resources: Get a free trial to Credit Repair Cloud Get my free credit repair training   Fastest Wins in Credit Repair: 7 Things You Can Delete In DAYS Make sure to subscribe so you stay up to date with our latest episodes.

What if the reason you're burned out isn't delegation—but the fact that you're managing other people's approval instead of leading?You don't struggle with delegation, you struggle with giving clear feedback to the people whose approval you think you need. In this Thursday quick-hit, Dawn breaks down why senior hires trigger softened communication, midnight rewrites, and CEO exhaustion and how learning to hold someone else's disappointment is the real leadership skill that removes bottlenecks. If you're rewriting work at 11 PM to “be nice,” this episode will hit uncomfortably close to home (in the best way).Ready to stop managing approval and start leading with clarity? Join the free AI for Founders Community a room full of founders learning to delegate, give feedback, and lead without the approval economy running their business.Key TakeawaysYou're not bad at feedback, you're inconsistent. You give crystal-clear direction to people whose approval you don't need…and hedge endlessly with the ones you're afraid to disappoint.You're running two delegation systems. One clear. One softened. That split is what's exhausting you, not your team.Approval is expensive. Rewriting emails, taking work back, and fixing things at midnight is an invisible approval tax on your CEO time.This isn't about their feelings it's about your story. You're not managing their disappointment. You're managing the fear of what their disappointment might “prove” about you.AI can expose your approval patterns fast. When emotions muddy leadership language, AI can objectively show you where you hedge, soften, and self-protect.Before you give feedback, ask yourself: “Am I softening this because they can't handle clarity or because I'm afraid of losing their approval?”If it's the second one, that's not kindness. That's self-protection.Leadership requires learning how to hold someone else's disappointment without making it your emergency.Use AI as your approval detector:Prompt:“Analyze my feedback patterns. Below are three emails to junior team members and three to senior team members. Identify where my language shifts from direct to hedging, where I manage reactions instead of stating expectations, and rewrite the senior feedback with the same clarity used for juniors.”You'll see the pattern immediately and once you see it, you can't unsee it.Resources & LinksJoin the Community: AI for Founders Free GroupFreebie: The Feedback FixRelated Episodes:Ep. 125 | The 3-Text Test: How Female Founders Use AI to Stop Their Team From Treating Them Like Google— communication clarity + boundaries.Ep. 124 | How Smart CEOs Build SOPs Without Boring Themselves (or Their Teams)— systems that reduce unnecessary manager workload. Send us Fan MailWant to increase revenue and impact? Listen to “She's That Founder” for insights on business strategy and female leadership to scale your business. Each episode offers advice on effective communication, team building, and management. Learn to master routines and systems to boost productivity and prevent burnout. Our delegation tips and business consulting will advance your executive leadership skills and presence.

Get the facts, without the spin. UNBIASED offers a clear, impartial recap of US news, including politics, elections, legal news, and more. Hosted by lawyer Jordan Berman, each episode provides a recap of current political events plus breakdowns of complex concepts—like constitutional rights, recent Supreme Court rulings, and new legislation—in an easy-to-understand way. No personal opinions, just the facts you need to stay informed on the daily news that matters. If you miss how journalism used to be, you're in the right place. In today's episode: U.S. and Iran Reach Agreement to End War. Here's What We Know. (0:51) DOJ "Approves" Paramount/Warner Bros Merger. Here's What That Means. (10:54) New Report Says Social Security Reserves Will Run Out in 2032, Sooner Than Expected. Here's What You Need to Know. (~21:54) Quick Hitters (~30:04) GOOD NEWS (~39:56) Critical Thinking Segment (~44:59) ⁠Watch⁠ this episode on YouTube. Follow Jordan on ⁠Instagram⁠ and ⁠TikTok⁠. All sources for this episode can be found ⁠here.⁠  Learn more about your ad choices. Visit podcastchoices.com/adchoices

-Think about that for a second---fans have been filling the stadium since 1962 and often times leave with a sour taste in their mouth. Outside ofa few concerts here and there, and the Volleyball Day in Nebraska…it's not often you can leave a packed stadium knowing you'll be happy-No one really cares about who wins in the Savannah Bananas games, and seeing Tom Osborne being honored just makes it more of a party likeit was…Our Sponsors:* Check out Hims and use my code hims.com/EARLYBREAK for a great deal: https://www.hims.com* Check out Progressive: https://www.progressive.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Do you ever walk into a room and immediately start wondering what people think of you?Maybe you replay what you said after a conversation. Maybe you hold back because you don't want to seem awkward, too eager, too quiet, too intense, or too much. Or maybe you find yourself performing instead of actually being present.

Do you ever walk into a room and immediately start wondering what people think of you?Maybe you replay what you said after a conversation. Maybe you hold back because you don't want to seem awkward, too eager, too quiet, too intense, or too much. Or maybe you find yourself performing instead of actually being present.

A major new retirement village overlooking Auckland's waterfront at Mission Bay has been given the green light under the government's fast track approvals process. Ngati Whatua Orakei Trust Chair, Marama Royal spoke to John Campbell.

Let me start with a piece of paper. Early in the twentieth century a printed rate card circulated among the opera houses of Italy, a schedule of charges from a claque, one of the applause brigades that worked the great houses of Europe. Approval came in grades, and the grades came at prices. Polite appreciation cost little. Insistence cost more. Down at the luxury end, for a wild ovation at any cost, the price became a sum to be arranged. A psychologist named Robert Cialdini reprinted that tariff decades later in his study of social proof, where it sits among the laboratory findings like a fossil among X-rays, the same animal at two stages of preservation.Now move forward a hundred years. A company in West Palm Beach sold the same product from a drop-down menu, five hundred followers for ten dollars, more than two hundred million of them moved before a newspaper took the operation apart in 2018. The invoice was older than the empire that first printed it.

No one is programmed for disapproval. Learn how to become who you really want to be. #ThePitch #INICIVOX #VirtualMentorship

A single, once-weekly tablet could change HIV treatment landscape; weight loss drug orforglipron efficacy assessed at all stages of menopause; hemophilia treatment Hympavzi gains expanded indication; and the FDA adds a warning label for kidney injury to an over-the-counter weight loss aid.

The desire to be accepted can easily cause us to compromise our values and drain our peace. Just as Aaron built the golden calf out of fear of the crowd, people-pleasing ultimately damages our relationship with God. Discover how finding your secure identity in God's unconditional love frees you from the exhausting need for human approval today.

You do not need to be the biggest. You need to be the fastest. In this episode of The Level Up Podcast, Paul Alex breaks down the agility advantage and why small businesses can use speed to beat massive competitors. Let's be real… Big companies have money. They have staff. They have market share. But they also have red tape. Approval chains. Slow decisions. And endless friction. That is where you can win. In this episode, you'll learn: Why size can create massive operational friction How small businesses can use speed as a competitive weapon Why acting too corporate too early destroys your advantage How rapid execution and fast pivots help you steal market share The truth is simple: A giant company may take four months to approve a campaign. You can make the move this week. They may need a board meeting. You can make a decision today. They may be trapped in bureaucracy. You can listen to the market, adjust the offer, and launch before they even react. That is the power of agility. Most small businesses lose because they try to look bigger than they are. High-level operators use their size as an advantage. They stay lean. They move fast. They trust their team. They strike while the giants are sleeping. Speed creates separation. Agility creates opportunity. Execution creates market share. Stay lean. Move fast. And keep leveling up. Your Network is your NETWORTH! Make sure to add me on all SOCIAL MEDIA PLATFORMS: Instagram: https://jo.my/paulalex2024Facebook: https://jo.my/fbpaulalex2024YouTube: https://www.youtube.com/channel/UCGhDAD1JyGGzSQUPD9lc9HQLinkedIn: https://jo.my/inpaulalex2024 Looking for a secondary source of income or want to become an entrepreneur? Check out one of my companies below to see if we can help you: www.CashSwipe.com FREE Copy of my book “Blue to Digital Gold - The New American Dream”www.officialPaulAlex.com Learn more about your ad choices. Visit megaphone.fm/adchoices

What if the life you're working so hard to build isn't actually the life you want? In this powerful episode, Lori A. Harris explores the tension between inherited ambitions and authentic fulfillment. Many of us unknowingly follow scripts handed down by family, culture, and society chasing achievements that look successful from the outside while feeling disconnected on the inside. Lori unpacks how people-pleasing, achievement addiction, and external validation can shape our identities and leave us feeling restless despite reaching our goals. Through personal stories and thought-provoking insights, she challenges listeners to examine whether their ambitions truly belong to them. This conversation is an invitation to stop postponing your desires, reconnect with your values, and redefine success on your own terms. If you've ever wondered why achieving more doesn't always feel better, this episode is for you. If you would like some help with figuring out how to transform your life! I can help you create a vision for a life that you absolutely love living. Click here to arrange a session with me. If you're enjoying the podcast, please share the show with a friend or, even better, leave a review to ensure others can benefit from it too! WHAT YOU WILL LEARN FROM THIS EPISODE How inherited beliefs shape your definition of success Why high achievers often feel disconnected from fulfillment The hidden consequences of people-pleasing How achievement can become part of your identity Why your emotions and body provide valuable guidance FREE GIFT FROM LORI  Free Audio Life Assessment: What Do You Really Crave? If today's episode still hit a nerve, this was made for you. I created this free 13-minute audio experience to give you the space to finally hear yourself across the five areas of your life that matter most. No scores. No grades. No performance required. Just you and your honest answers to questions that lead you back to what you actually want. Get instant access now at thelifeassessment.com FEATURED ON THE SHOW: If you're enjoying the podcast, I'd love to hear from you! Please share the show with a friend or even better, leave a review to ensure others can benefit from the podcast.

Today's Scripture: Jeremiah 17:5–8 In this episode, Dr. Alison Cook reflects on the powerful image of a tree planted by water. She explores what happens when we ask approval, productivity, perfectionism, control, or another person's response to carry the full weight of our security. We explore: *Why needing people is not the problem—but making one person your source can drain your soul *How approval, productivity, perfectionism, and control can become fragile root systems *Why fear-based attachment makes it hard to receive goodness *How to become like a tree planted by water, steady even when heat or drought comes *How secure attachment with God helps you receive love without clinging to it Connect with Dr. Alison on Instagram: @dralisoncook Join 80,000+ Soul Menders in Dr. Alison's free email community for ongoing reflection and support. While Dr. Cook is a counselor, the content of this podcast and any of the products provided by Dr. Cook are not specific counseling advice nor are they a substitute for individual counseling. The content and products provided on this podcast are for informational purposes only.‍ Learn more about your ad choices. Visit megaphone.fm/adchoices

After months of contentious debate, San Diego city leaders unanimously approved the budget for fiscal year 2027. And, San Diego's largest school district is moving fully online for enrollment next school year. Plus, the county fair officially opens today! NBC7's Marianne Kushi has those stories alongside meteorologist Sheena Parveen with your forecast on June 10, 2026.

⚡ Want Faster Divorce Approval? Do THIS First | Los Angeles Divorce ⚖️ Want a judge to approve your divorce settlement faster? Here's the truth: judges don't care about emotional speeches or who was “more right.” They care about paperwork that's complete, clear, and legally correct. In this video, I explain how to prepare a clean, court-ready divorce settlement that avoids rejections and moves through the court system quickly.

June 8, 2026; 6pm: President Trump formally nominates his former personal lawyer, Todd Blanche, to serve as attorney general. Plus, new lies from Trump about the war in Iran. MS NOW's Ari Melber reports on the latest developments and is joined by Howard Dean, former Vermont governor and former DNC chair and Andrew Weissmann, former Mueller prosecutor. To listen to this show and other MS podcasts without ads, sign up for MS NOW Premium on Apple Podcasts. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this Hot Topics episode, I'm joined by Detroit-area dermatologist Dr. Emily Levin to cover some of the most talked-about topics in skincare and cosmetic medicine right now. We're breaking down the 30-second face-washing rule, the dangerous looksmaxxing trend your kids already know about, why I think under-eye filler is one of the trickiest treatments out there, a new minimally invasive fat reduction procedure, the rise of the mini lunchtime breast job, and what Kelly Ripa microneedled that definitely wasn't her face. Topics Discussed:  → What is the 30-second face-washing rule?  → What is looksmaxing, and why is it dangerous?  → Why should you reconsider under-eye filler?  → What is Quantum RF skin tightening?  → Can you get a mini lunchtime breast job with fat transfer?  → What did Kelly Ripa microneedle…and did it actually work?

Today: Affordable rental housing could be coming to long-vacant lots across Mansfield, as a developer’s plan for scattered-site homes moves one step closer to reality.Support the show: https://richlandsource.com/membersSee omnystudio.com/listener for privacy information.

Whether it's cooking, music, art, or simply how we move through the world, Andy reflects on how difficult it can be to create without attaching our self-worth to other people's reactions. Learn more about your ad choices. Visit megaphone.fm/adchoices

Why do modern men have everything they ever wanted, yet still feel isolated, overworked, and unfulfilled?  In this unfiltered episode of The Modern Man Podcast, host Ted Phaëton sits down with ultra-endurance athlete, health coach, and Mission 22 advocate Marcus Farris to dissect masculine psychology, extreme physical resilience, and the painful transition from the "Young Warrior" to the "Wise King."  Marcus shares his raw, lived experience of surviving a life-shattering divorce, transitioning out of military team environments, and why voluntary suffering is the ultimate prophylactic against a world that will inevitably punch you in the face. If you are a CEO, entrepreneur, father, or leader trying to break free from the "relevance trap," this clinical, no-BS conversation is your blueprint to rebuild your internal capacity for life.  Chapters: 00:00 - The Shattered Ego: Surviving My Divorce 02:09 - Why Modern Men Avoid Suffering (The Eudaemonia Blueprint) 03:51 - Is Your Life Wound Cynical or Sacred? 05:27 - Strength Is For Service, Not Status (Romans 15 Audit) 07:40 - Muay Thai, Hyrox, and Physical Competence 10:31 - How to Break the Ossified Mind Through Body Movement 13:27 - Pushing Past the Mile 20 Breaking Point (Peaks and Troughs) 19:15 - Escaping the Matrix of Habitual Drinking (My First Sobriety Race) 24:51 - Gen Z Screen Addiction vs. Moving Meditation 28:34 - The Ultimate Ego Audit: Relevance vs. Togetherness 37:00 - The Archetypal Transition: Young Warrior to Wise King 41:25 - How to Properly Validate Yourself (Stopping the Search for Approval) 45:19 - Rebuilding the Paternal Bond: The "Male Mother" Archetype 47:15 - Combating Veteran Suicide: The Mission 22 Movement 48:34 - What Every Man Must Do When Life Gets Heavy   Farris's Links: Website:  Support Mission 22 (Veteran Suicide Prevention): https://mission22.org Instagram: https://www.instagram.com/ultrarunfarris/ Facebook: https://www.facebook.com/davidcmunson   ⚔️JOIN THE NOBLE KNIGHTS MASTERMIND⚔️ https://themodernmanpodcast.com/thenobleknights   

Most people think rejection is just emotional pain, but the deeper issue is often spiritual. Dr. Greg Gifford explains how misplaced identity, fear of man, and people pleasing create cycles of insecurity, hypersensitivity, and relational instability. Discover how confidence in Christ—not human approval—becomes the foundation for lasting peace, resilience, and wisdom.  Transformed Podcast Episode 178 | June 04, 2026 ___ Thanks for listening! Transformed would not be possible without the financial support of our Gospel Partners. If you would like to support Transformed we would be extremely grateful. VISIT https://fortisinstitute.org/donate/ If you are already a Gospel Partner we couldn't be more thankful for you if we tried!

Send us Fan MailHave you ever found yourself wanting to go back to something you already know you've outgrown?Maybe it's an old relationship.An old habit.A scarcity mindset.A way of thinking that feels familiar, even though it keeps you small.This morning, I sat down in my chair and heard one clear phrase in my spirit:Don't go back to Egypt.And I knew immediately what it meant.In the Bible, Egypt wasn't just a place. It represented bondage, captivity, limitation, and survival. The Israelites physically left Egypt in one night, but it took much longer to get the mindset of Egypt out of them.And honestly? I think we all have places like that.We can leave a toxic relationship but still carry toxic thinking.We can leave scarcity but still make every decision from fear.We can leave insecurity but still crave validation from everyone around us.We can step into freedom but still feel pulled backward by familiarity.That's the danger.Sometimes bondage feels safer simply because it's predictable. Freedom feels unfamiliar. Growth feels uncomfortable. The wilderness feels uncertain. But discomfort does not mean you're going in the wrong direction.In this episode, I'm talking about how to stop romanticizing the very things God delivered you from and how to renew your mind for the next season of your life.Because you cannot sustain a promised-land life with a slave mentality.You have to think differently. Speak differently.  Expect differently. And sometimes, you have to bless the past while deciding it no longer belongs in your future.I also share a personal moment when I realized I was being drawn back toward a relationship from my past. There was nothing wrong with the person, but I knew it wasn't where my future was. And sometimes that's the hardest part: recognizing that something can be good, meaningful, and valuable for a season without being meant to continue forever.If you've been circling the same mountain, revisiting the same fear, or feeling tempted to shrink back into what's comfortable, this episode is for you.Your future self will thank you for moving forward.Your future generations will thank you for moving forward.And the life God has for you is too important to spend staring into the rearview mirror.Don't go back to Egypt.Keep putting one foot in front of the other.Keep renewing your mind.Keep moving forward.You truly are more!Connect With Us:Website: https://www.youaremore.comJoin The 6AM Club Bible Study! Bible Study: https://www.youaremore.com/bible-study Free Download: 5 Steps to Win Through Adversity https://youaremorepodcast.com/store Social Media: Follow us on Facebook https://www.facebook.com/youaremorepodcast and Instagram https://www.instagram.com/amywienands/ Email: amy@amywienands.comEpisode Minute By Minute:00:00 – Weekly Bible Study Invitation + “Don't Go Back to Egypt”01:00 – Egypt Is More Than a Place: It Can Become a Mentality02:20 – Leaving Fear, Scarcity, and Toxic Thinking Behind03:15 – Exodus Was Easy, Transformation Was Hard04:20 – Why Familiar Bondage Can Feel Safer Than Freedom05:15 – Modern-Day Egypt: Limiting Beliefs, Approval, and Comfort06:10 – The Responsibility That Comes With Freedom07:05 – You Were Never Meant to Build Your Identity in Struggle08:10 – Stop Emotionally Revisiting Egypt09:00 – Don't Remember the Bread and Forget the Bondage10:00 – Amy's Personal Realization About a Past Relationship11:00 – Why Romanticizing the Past Keeps You From Evolving12:00 – Egypt Is Always Trying to Pull You Back13:00 – You Can't Sustain a Promised-Land Life With Slave Thinking14:00 – Discomfort Does Not Mean You're Going the Wrong Way15:00 – Sometimes You Only Get the Next Step16:00 – The Wilderness Is Preparation, Not Punishment17:00 – Old Relationships, Old Habits, and Old Versions of Yourself18:00 – Freedom May Feel Unfamiliar, But That Doesn't Mean Unsafe19:00 – You Were Not Called to Live in Survival Mode20:00 – Stop Looking Backward and Keep Moving Forward21:00 – Final Encouragement: You Win and You Truly Are MoreBe intentional, stay focused, and remember you are more! 

You've been filling your days to the brim and calling it faithfulness. Every hour accounted for. Every margin eliminated. You pull it all off, too, and you reach the end of the day unable to say why it felt empty. The people you love most were technically present, but you couldn't really see them. You measured the day by what got done, not by who got loved. And underneath the productivity, if you're honest, there was a quieter engine running — the fear that if you slowed down, you'd have to sit with something you're not ready to face. Tyler Staton, lead pastor of Bridgetown Church in Portland, author of Praying Like Monks Living Like Fools, The Familiar Stranger, and his newest book After Amen, joins me for what I believe is one of the most theologically precise and personally confronting conversations this show has produced. Tyler has walked through a stage-four cancer diagnosis and come through it with a startling clarity about what the soul actually needs. In this conversation we cover the holiness of unfinished things, how to distinguish Spirit-led submission from fear-driven people-pleasing, what it means to absorb the wrongs of another without becoming a doormat, why approval addiction and genuine love cannot coexist in the same moment, and what Jesus's own relationship to human limits reveals about how we were designed to live. What Tyler says about the Kingdom of God is worth stopping on. The Kingdom only comes in the present, he argues, and when you're living in your head, toward the next thing, you cannot participate in it. This isn't a productivity hack. It's a diagnosis of a spiritual condition most of us have normalized. The hurry we've made peace with is the very thing severing us from the people we love, the voice of the Spirit we say we want, and the joy we keep expecting to find somewhere ahead. What you'll find in this conversation is not comfort. You'll find a mirror. Tyler names the lie that high-achievers and approval-seekers share in common: that more urgency and more effort will eventually produce the love and belonging we're chasing, and he tells you exactly why that trade will cost you your soul. This conversation will ask something of you. The question is whether you're ready to slow down enough to hear it. Guest Bio Tyler Staton is the lead pastor of Bridgetown Church in Portland, Oregon, and the national director of 24-7 Prayer USA. He is the author of Praying Like Monks, Living Like Fools, The Familiar Stranger — a book about encountering the Holy Spirit as a living Person — and his newest release, After Amen: 50 Days of Poetry and Prayer, written in the aftermath of a stage-four cancer diagnosis and the particular clarity that kind of wilderness produces. Tyler lives in Portland with his wife Kirsten, and their three sons. His work sits at the intersection of contemplative prayer, Spirit-led formation, and the kind of pastoral honesty that refuses to separate theological depth from ordinary daily life. Show Partner SafeSleeve designs a phone case that blocks up to 99% of harmful EMF radiation—so I'm not carrying that kind of exposure next to my body all day. It's sleek, durable, and most importantly, lab-tested by third parties. The results aren't hidden—they're published right on their site. And that matters because many so-called EMF blockers on the market either don't work or can't prove they do. We protect our hearts and minds—why wouldn't we protect our bodies too? Head to safesleevecases.com and use the code WINTODAY10 for 10% off your order. Episode Links Show Notes Buy my book "Healing What You Can't Erase" here! Invite me to speak at your church or event. Connect with me @WINTODAYChris on Instagram, Facebook, Twitter, and YouTube.

If you have ever felt uneasy about a prescription but could not quite explain why, this episode is for you. Not because the goal is to scare you, but because you deserve to understand how the system actually works — from someone who worked inside it for years. Welcome I am a Registered Nurse and Christian holistic health coach, and before I ever coached women toward natural healing, I spent years inside the pharmaceutical industry working in drug safety and pharmacovigilance. I processed the reports. I saw the conflicts of interest. And eventually, I became the patient. This episode is for the Christian woman who has been dismissed, medicated, and sent home with a prescription and zero real answers. The woman who suspects there is a better way but does not know where to start. If that is you, keep listening. What the Drug Approval Process Actually Looks Like Most people assume that by the time a drug reaches your pharmacist, it has been tested on hundreds of thousands of people over decades. The reality is more sobering. Before a drug is approved, it goes through clinical trials. For your average drug, the median total number of participants across all clinical trials before FDA approval is 1,708 people. For orphan drugs — drugs created for rare diseases — that number drops to a median of 438 participants. That is the data your doctor's prescription is based on. The Conflict of Interest Nobody Talks About Here is what most people outside the industry do not know. When a patient has an adverse event during a clinical trial, a report gets sent to the drug safety department. A physician is then required to determine whether or not the drug caused that event. But that physician works for — or is contracted by — the pharmaceutical company. The chief medical officer, the person setting the tone for how reports are assessed, has a financial stake in the outcome. Even the most ethical physician in that position faces a fundamental conflict of interest. And in some cases, if the clinical trial investigator — the doctor actually watching the patient — determines the drug caused the adverse event, the pharmaceutical company's physician can override that assessment entirely. The Human Factor Inside the System The people who work in drug safety are largely detail-oriented, hardworking, and genuinely care about patient outcomes. That matters and it is worth saying. But the system itself has real limitations. High turnover rates mean institutional knowledge walks out the door constantly. Clinical trial teams spread across the globe sometimes do not understand their own reporting obligations. Physicians reviewing dozens of nearly identical reports daily are fighting boredom and burnout. And patients taking 10, 15, or even 30 medications at once make causality nearly impossible to determine with any real certainty. The science is not as clean as the packaging suggests. After FDA Approval — The Data Gets Even Thinner Once a drug is on the market, the primary way a pharmaceutical company learns about safety issues is through voluntary reports — from you or your doctor. Most patients have never heard of a pharmacovigilance department. Most healthcare professionals do not know they can or should be reporting adverse events directly to pharmaceutical companies. That means the post-market safety data is largely dependent on a system most people do not know exists. Vioxx is the example that opened this episode. FDA approved. Widely prescribed. Pulled from the market after data showed an increased risk of heart attacks and strokes. The clinical trials passed. The stamp of approval was given. And people were still harmed. What This Means for Your Health Decisions None of this means every pharmaceutical product is dangerous or that every person working in the industry has bad intentions. That is not the point. The point is discernment. The safety profile of the drug you may be taking rests heavily on the worldview of one chief medical officer at one pharmaceutical company, filtered through a reporting system most people have never heard of, built on a data set far smaller than most people realize. That is not a conspiracy. That is just how the system is structured. Why God Must Come First My friend had Crohn's disease for roughly 15 years. One day she was healed. Her doctor's response? It must be that you never had Crohn's disease in the first place. That response reveals everything about a worldview that cannot make room for healing outside of its own framework. God is not limited by what the data set allows. He is not constrained by what the chief medical officer approves. His wisdom is complete, and He designed your body with purpose and precision. I am not here to get you off your medications. I am not here to tell you pharmaceutical companies are entirely bad. My mission is simpler and more important than that — to encourage you to go to God first. To seek His wisdom before you outsource your health to a system that was never designed to heal you. As one of my dear friends shared with me for my book, Discover God's Health Wisdom: Science and knowledge are gifts from the Almighty One, yet they are not God. When we believe the deception that academia, research, and humanity's partial understanding is more powerful than the One who created it all, then it controls us and leaves us susceptible to more deception. Time-Stamped Highlights 0:01 — The Vioxx story: what it reveals about FDA approval and drug safety 1:00 — What pharmacovigilance is and why most people have never heard of it 3:51 — The good inside the system: the people who genuinely care 4:17 — The chaotic human factor and the God complex in conventional medicine 7:08 — The conflict of interest at the heart of drug safety assessments 9:29 — The clinical trial data sets: how many people a drug is actually tested on 11:22 — Post-market reporting and why the data gets thinner after approval 13:15 — Why comorbidities and polypharmacy make causality nearly impossible to assess 16:31 — How a physician's worldview shapes the safety conclusions of an entire drug program 17:56 — The invitation: go to God first for your health Key Takeaways Drug approvals are based on smaller data sets than most people assume — medians of 1,708 participants for standard drugs and 438 for orphan drugs across all clinical trials The physician determining whether a drug caused an adverse event often works directly for the pharmaceutical company — a structural conflict of interest Post-market safety data depends largely on voluntary reporting from patients and doctors, most of whom do not know the system exists The science is real and has genuine value — but it is incomplete, human, and subject to bias like every other human system Seeking God's wisdom first does not mean rejecting medicine; it means approaching your health with discernment rather than blind trust True lasting healing is possible — and God's design for your body is more complete than any clinical trial Ready to Stop Outsourcing Your Health? If this episode stirred something in you — if you have been wondering whether there is a better path forward for your energy, your autoimmune symptoms, or your overall health — I want to invite you to book a More Energy Strategy Session with me. This is a private, one-on-one conversation where we look at what is actually going on in your body and begin building a path forward rooted in God's design for your health. Not another prescription. Not another dead end. If you are ready to stop spinning your wheels and start moving forward with clarity and confidence, the link is herholistichealing.com/services.   Sources Duijnhoven RG, Straus SM, Raine JM, de Boer A, Hoes AW, De Bruin ML. "Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis." PLOS Medicine, March 19, 2013. Full study: https://pmc.ncbi.nlm.nih.gov/articles/PMC3601954/   This content is for informational purposes only and is not meant to be medical advice.

(8) Evan Ellis previews Pope Leo's historic visit to South America, including his former missionary grounds. In Argentina, President Milei struggles with declining approval as Peronist opposition organizes for future electoral challenges.80 BCE